[Importance of the administration of synacthen (beta 1-24 corticotropin) in the therapeutic protocol of patients with neoplasms in an advanced stage].
D000324:Adrenocorticotropic Hormone / Q000031:analogs & derivatives*; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D003366:Cosyntropin / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013997:Time Factors
D000970:Antineoplastic Agents; D003366:Cosyntropin; C006418:adrenocorticotropin zinc; D000324:Adrenocorticotropic Hormone
"Intérêt de l'administration du Synacthène (beta 1-24 corticotrophine) dans le protocole thérapeutique des malades atteints de néoplasmes en période avancée.